RT Journal Article
SR Electronic
T1 Improving Risk Assessment
JF Science Translational Medicine
FD American Association for the Advancement of Science
SP 159ps22
OP 159ps22
DO 10.1126/scitranslmed.3003497
VO 4
IS 159
A1 Dambach, Donna M.
A1 Uppal, Hirdesh
YR 2012
UL http://stm.sciencemag.org/content/4/159/159ps22.abstract
AB Widespread sharing and analysis of clinical trial data and a U.S. government initiative to engineer nonclinical cell-based models that mimic human biological processes have the potential to improve predictions of drug-related adverse events.